{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T14:45:59Z","timestamp":1782225959788,"version":"3.54.5"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T00:00:00Z","timestamp":1540252800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["PdCCRS_1139464"],"award-info":[{"award-number":["PdCCRS_1139464"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007210","name":"Varian Medical Systems","doi-asserted-by":"publisher","award":["30407"],"award-info":[{"award-number":["30407"]}],"id":[{"id":"10.13039\/100007210","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12885-018-4916-2","type":"journal-article","created":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T17:10:35Z","timestamp":1540314635000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["TROG 15.03 phase II clinical trial of Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney - FASTRACK II"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2840-0658","authenticated-orcid":false,"given":"Shankar","family":"Siva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent","family":"Chesson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Bressel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Pryor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Braden","family":"Higgs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayley M.","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Hardcastle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Montgomery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Vanneste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Khoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Ruben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eddie","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Hofman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"De Abreu Lourenco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swetha","family":"Sridharan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas R.","family":"Brook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarad","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Lawrentschuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Kron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farshad","family":"Foroudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,23]]},"reference":[{"key":"4916_CR1","unstructured":"AIHW A: Cancer in Australia: an overview, 2014. AIHW, Cancer Series no 90, Cat no CAN 88 Canberra 2014."},{"issue":"2","key":"4916_CR2","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87\u2013108.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"4916_CR3","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.juro.2012.03.006","volume":"188","author":"SP Kim","year":"2012","unstructured":"Kim SP, Thompson RH, Boorjian SA, Weight CJ, Han LC, Murad MH, Shippee ND, Erwin PJ, Costello BA, Chow GK. Comparative effectiveness for survival and renal function of partial and radical nephrectomy for localized renal tumors: a systematic review and meta-analysis. J Urol. 2012;188(1):51\u20137.","journal-title":"J Urol"},{"key":"4916_CR4","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/j.juro.2014.04.016","volume":"192","author":"S Demirjian","year":"2014","unstructured":"Demirjian S, Lane BR, Derweesh IH, Takagi T, Fergany A, Campbell SC. Chronic kidney disease due to surgical removal of nephrons: relative rates of progression and survival. J Urol. 2014;192:1057.","journal-title":"J Urol"},{"issue":"1","key":"4916_CR5","doi-asserted-by":"publisher","first-page":"201","DOI":"10.2214\/ajr.183.1.1830201","volume":"183","author":"RJ Zagoria","year":"2004","unstructured":"Zagoria RJ, Hawkins AD, Clark PE, Hall MC, Matlaga BR, Dyer RB, Chen MY. Percutaneous CT-guided radiofrequency ablation of renal neoplasms: factors influencing success. Am J Roentgenol. 2004;183(1):201\u20137.","journal-title":"Am J Roentgenol"},{"issue":"7","key":"4916_CR6","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1097\/JTO.0b013e3181de7143","volume":"5","author":"S Siva","year":"2010","unstructured":"Siva S, MacManus M, Ball D. Stereotactic radiotherapy for pulmonary oligometastases: a systematic review. J Thorac Oncol. 2010;5(7):1091\u20139.","journal-title":"J Thorac Oncol"},{"issue":"9","key":"4916_CR7","doi-asserted-by":"publisher","first-page":"e109","DOI":"10.1016\/j.clon.2016.04.002","volume":"28","author":"JH Chang","year":"2016","unstructured":"Chang JH, Cheung P, Erler D, Sonier M, Korol R, Chu W. Stereotactic ablative body radiotherapy for primary renal cell carcinoma in non-surgical candidates: initial clinical experience. Clin Oncol (R Coll Radiol). 2016;28(9):e109\u201314.","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"3","key":"4916_CR8","doi-asserted-by":"publisher","first-page":"S349","DOI":"10.1016\/j.ijrobp.2006.07.656","volume":"66","author":"B Gilson","year":"2006","unstructured":"Gilson B, Lederman G, Qian G, Fastaia M, Cangiane L. Hypo-fractionated stereotactic extra-cranial radiosurgery (HFSR) for primary and metastatic renal cell carcinoma. Int J Radiat Oncol Biol Phys. 2006;66(3):S349\u2013S.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"4916_CR9","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3892\/ol.2014.2129","volume":"8","author":"CH Lo","year":"2014","unstructured":"Lo CH, Huang WY, Chao HL, Lin KT, Jen YM. Novel application of stereotactic ablative radiotherapy using CyberKnife for early-stage renal cell carcinoma in patients with pre-existing chronic kidney disease: initial clinical experiences. Oncol Lett. 2014;8(1):355\u201360.","journal-title":"Oncol Lett"},{"issue":"2","key":"4916_CR10","doi-asserted-by":"publisher","first-page":"S84","DOI":"10.1016\/j.ijrobp.2013.06.218","volume":"87","author":"SM McBride","year":"2013","unstructured":"McBride SM, Wagner AA, Kaplan ID. A phase 1 dose-escalation study of robotic radiosurgery in inoperable primary renal cell carcinoma. Int J Radiat Oncol Biol Phys. 2013;87(2):S84.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"4916_CR11","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/bju.13811","volume":"120","author":"S Siva","year":"2017","unstructured":"Siva S, Pham D, Kron T, Bressel M, Lam J, Tan TH, Chesson B, Shaw M, Chander S, Gill S, et al. Stereotactic ablative body radiotherapy for inoperable primary kidney cancer: a prospective clinical trial. BJU Int. 2017;120(5):623\u201330.","journal-title":"BJU Int"},{"issue":"9","key":"4916_CR12","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/nrurol.2017.87","volume":"14","author":"S Siva","year":"2017","unstructured":"Siva S, Kothari G, Muacevic A, Louie AV, Slotman BJ, Teh BS, Lo SS. Radiotherapy for renal cell carcinoma: renaissance of an overlooked approach. Nat Rev Urol. 2017;14(9):549\u201363.","journal-title":"Nat Rev Urol"},{"issue":"11","key":"4916_CR13","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1007\/s11547-014-0402-3","volume":"119","author":"YJ Wang","year":"2014","unstructured":"Wang YJ, Han TT, Xue JX, Chang DS, Li HQ, Li P, Wang JD, Wang YJ, Xia TY. Stereotactic gamma-ray body radiation therapy for asynchronous bilateral renal cell carcinoma. Radiol Med. 2014;119(11):878\u201383.","journal-title":"Radiol Med"},{"issue":"11 Pt B","key":"4916_CR14","doi-asserted-by":"publisher","first-page":"E737","DOI":"10.1111\/j.1464-410X.2012.11550.x","volume":"110","author":"S Siva","year":"2012","unstructured":"Siva S, Pham D, Gill S, Corcoran NM, Foroudi F. A systematic review of stereotactic radiotherapy ablation for primary renal cell carcinoma. BJU Int. 2012;110(11 Pt B):E737\u201343.","journal-title":"BJU Int"},{"issue":"5","key":"4916_CR15","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.ijrobp.2014.07.043","volume":"90","author":"D Pham","year":"2014","unstructured":"Pham D, Thompson A, Kron T, Foroudi F, Kolsky MS, Devereux T, Lim A, Siva S. Stereotactic ablative body radiation therapy for primary kidney cancer: a 3-dimensional conformal technique associated with low rates of early toxicity. Int J Radiat Oncol Biol Phys. 2014;90(5):1061\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"4916_CR16","doi-asserted-by":"publisher","first-page":"S96","DOI":"10.1016\/j.ijrobp.2016.06.240","volume":"96","author":"S. Siva","year":"2016","unstructured":"Siva S, Pham D, Tan T, Lam J, Bressel M, Jackson P, Gill S, Shaw M, Tai K, Violet J. Principal analysis of a phase Ib trial of stereotactic body radiation therapy (SBRT) for primary kidney Cancer. Int J Radiat Oncol Biol Phys. 2016;96(2S):S96.","journal-title":"International Journal of Radiation Oncology*Biology*Physics"},{"issue":"1","key":"4916_CR17","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.radonc.2015.08.030","volume":"117","author":"L Ponsky","year":"2015","unstructured":"Ponsky L, Lo SS, Zhang Y, Schluchter M, Liu Y, Patel R, Abouassaly R, Welford S, Gulani V, Haaga JR. Phase I dose-escalation study of stereotactic body radiotherapy (SBRT) for poor surgical candidates with localized renal cell carcinoma. Radiother Oncol. 2015;117(1):183\u20137.","journal-title":"Radiother Oncol"},{"issue":"3","key":"4916_CR18","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.juro.2014.08.044","volume":"193","author":"M Staehler","year":"2015","unstructured":"Staehler M, Bader M, Schlenker B, Casuscelli J, Karl A, Roosen A, Stief CG, Bex A, Wowra B, Muacevic A. Single fraction radiosurgery for the treatment of renal tumors. J Urol. 2015;193(3):771\u20135.","journal-title":"J Urol"},{"issue":"2 Supplement","key":"4916_CR19","doi-asserted-by":"publisher","first-page":"S84","DOI":"10.1016\/j.ijrobp.2013.06.218","volume":"87","author":"SM McBride","year":"2013","unstructured":"McBride SM, Wagner AA, Kaplan ID. A phase 1 dose-escalation study of robotic radiosurgery in inoperable primary renal cell carcinoma. Int J Radiat Oncol Biol Phys. 2013;87(2 Supplement):S84.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"4916_CR20","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1097\/COC.0000000000000329","volume":"41","author":"RJ Correa","year":"2018","unstructured":"Correa RJ, Rodrigues GB, Chen H, Warner A, Ahmad B, Louie AV. Stereotactic ablative radiotherapy (SABR) for large renal tumors. Am J Clin Oncol. 2018;41(6):568\u201375.","journal-title":"Am J Clin Oncol"},{"issue":"5","key":"4916_CR21","doi-asserted-by":"publisher","first-page":"637","DOI":"10.2217\/fon.16.2","volume":"12","author":"S Siva","year":"2016","unstructured":"Siva S, Ellis RJ, Ponsky L, Teh BS, Mahadevan A, Muacevic A, Staehler M, Onishi H, Wersall P, Nomiya T, et al. Consensus statement from the international radiosurgery oncology consortium for kidney for primary renal cell carcinoma. Future Oncol. 2016;12(5):637\u201345.","journal-title":"Future Oncol"},{"issue":"5","key":"4916_CR22","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1002\/cncr.31156","volume":"124","author":"S Siva","year":"2018","unstructured":"Siva S, Louie AV, Warner A, Muacevic A, Gandhidasan S, Ponsky L, Ellis R, Kaplan I, Mahadevan A, Chu W, et al. Pooled analysis of stereotactic ablative radiotherapy for primary renal cell carcinoma: a report from the international radiosurgery oncology consortium for kidney (IROCK). Cancer. 2018;124(5):934\u201342.","journal-title":"Cancer"},{"issue":"S12","key":"4916_CR23","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1002\/(SICI)1097-0142(19971215)80:12+<2519::AID-CNCR26>3.0.CO;2-E","volume":"80","author":"S Ning","year":"1997","unstructured":"Ning S, Trisler K, Wessels BW, Knox SJ. Radiobiologic studies of radioimmunotherapy and external beam radiotherapy in vitro and in vivo in human renal cell carcinoma xenografts. Cancer. 1997;80(S12):2519\u201328.","journal-title":"Cancer"},{"issue":"2","key":"4916_CR24","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"E Eisenhauer","year":"2009","unstructured":"Eisenhauer E, Therasse P, Bogaerts J, Schwartz L, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45(2):228\u201347.","journal-title":"Eur J Cancer"},{"issue":"8","key":"4916_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0202387","volume":"13","author":"HM Reynolds","year":"2018","unstructured":"Reynolds HM, Parameswaran BK, Finnegan ME, Roettger D, Lau E, et al. Diffusion weighted and dynamic contrast enhanced MRI as an imaging biomarker for stereotactic ablative body radiotherapy (SABR) of primary renal cell carcinoma. PLOS ONE. 2018;13(8):e0202387. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0202387\n                    \n                  .","journal-title":"PLOS ONE"},{"issue":"2","key":"4916_CR26","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s40273-017-0582-5","volume":"36","author":"Madeleine T. King","year":"2017","unstructured":"King MT, Viney R, Pickard AS, Rowen D, Aaronson NK, Brazier JE, Cella D, Costa DS, Fayers PM, Kemmler G, McTaggart-Cowen H. Australian utility weights for the EORTC QLU-C10D, a multi-attribute utility instrument derived from the cancer-specific quality of life questionnaire, EORTC QLQ-C30. PharmacoEconomics. 2018;36(2):225-38.","journal-title":"PharmacoEconomics"},{"issue":"5","key":"4916_CR27","first-page":"6944","volume":"20","author":"VJ Nair","year":"2013","unstructured":"Nair VJ, Szanto J, Vandervoort E, Cagiannos I, Breau R, Malone C, Avruch L, Pantarotto J, Malone S. Cyberknife for inoperable renal tumours: Canadian pioneering experience. Can J Urol. 2013;20(5):6944\u20139.","journal-title":"Can J Urol"},{"issue":"2","key":"4916_CR28","first-page":"S84","volume":"87","author":"T Nomiya","year":"2008","unstructured":"Nomiya T, Tsuji H, Hirasawa N, Kato H, Kamada T, Mizoe J. Carcbon ion radiation therapy for primary renal cell carcinoma: initial clinical experience. Int J Radiat Oncol Biol Phys. 2008;87(2):S84.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"4916_CR29","doi-asserted-by":"publisher","first-page":"S283","DOI":"10.1016\/S0360-3016(03)01136-2","volume":"57","author":"G Qian","year":"2003","unstructured":"Qian G, Lowry J, Silverman P, Grosman I, Makara D, Lederman G. Stereotactic extra-cranial radiosurgery for renal cell carcinoma. Int J Radiat Oncol Biol Phys. 2003;57(2):S283.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"4916_CR30","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.radonc.2015.08.030","volume":"117","author":"L Ponsky","year":"2015","unstructured":"Ponsky L, Lo SS, Zhang Y, Schluchter M, Liu Y, Patel R, Abouassaly R, Welford S, Gulani V, Haaga JR, et al. Phase I dose-escalation study of stereotactic body radiotherapy (SBRT) for poor surgical candidates with localized renal cell carcinoma. Radiother Oncol. 2015;117(1):183\u20137.","journal-title":"Radiother Oncol"},{"issue":"7","key":"4916_CR31","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1080\/02841860600954875","volume":"45","author":"C Svedman","year":"2006","unstructured":"Svedman C, Sandstrom P, Pisa P, Blomgren H, Lax I, Kalkner KM, Nilsson S, Wersall P. A prospective phase II trial of using extracranial stereotactic radiotherapy in primary and metastatic renal cell carcinoma. Acta Oncol. 2006;45(7):870\u20135.","journal-title":"Acta Oncol"},{"issue":"8","key":"4916_CR32","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1080\/02841860802123196","volume":"47","author":"C Svedman","year":"2008","unstructured":"Svedman C, Karlsson K, Rutkowska E, Sandstrom P, Blomgren H, Lax I, Wersall P. Stereotactic body radiotherapy of primary and metastatic renal lesions for patients with only one functioning kidney. Acta Oncol. 2008;47(8):1578\u201383.","journal-title":"Acta Oncol"},{"issue":"1","key":"4916_CR33","first-page":"e6","volume":"3","author":"BS Teh","year":"2007","unstructured":"Teh BS, Bloch C, Gali-Guevara M, Doh L, Richardson S, Chiang S. The treatment of primary and metastatic renal cell carcinoma (RCC) with image-guided stereotactic body radiation therapy (SBRT). Biomed Imaging Interv J. 2007;3(1):e6.","journal-title":"Biomed Imaging Interv J"},{"issue":"1","key":"4916_CR34","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.radonc.2005.03.022","volume":"77","author":"PJ Wers\u00e4ll","year":"2004","unstructured":"Wers\u00e4ll PJ, Blomgren H, Lax I, K\u00e4lkner KM, Linder C, Lundell G. Extracranial stereotactic radiotherapy for primary and metastatic renal cell carcinoma. Radiother Oncol. 2004;77(1):88\u201395.","journal-title":"Radiother Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4916-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-018-4916-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4916-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T06:48:50Z","timestamp":1571813330000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-018-4916-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,23]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["4916"],"URL":"https:\/\/doi.org\/10.1186\/s12885-018-4916-2","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,23]]},"assertion":[{"value":"8 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval has been obtained for the clinical sites currently recruiting to this multicentre study at the time of writing;Princess Alexandra Hospital, Peter MacCallum Cancer Centre, Royal Adelaide Hospital, Royal North Shore Hospital, Alfred Health, Calvary Mater Newcastle.Royal Brisbane and Women\u2019s Hospital, South Western Sydney Local Health District (Liverpool and Campbelltown Hospitals).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable as this protocol publication does not include patient information.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"1030"}}